INTRODUCTION AP-1 transcription complexes are dimers mainly composed of members of the Fos (c-Fos, Fra-1, Fra-2 and FosB) and Jun (c-Jun, JunB and JunD) transcription factors. They bind 12-Otetradecanoylphorbol 13-acetate (TPA)-responsive elements (TRE) found in many gene promoters, explaining their central role in many aspects of cell physiology.
1,2 AP-1 complexes are also essential for tumorigenesis in many situations, either as causative agents or as effectors of upstream oncogenes. [3] [4] [5] [6] AP-1 activity is regulated at various levels, including composition of dimers, level of expression, stability and post-translational modifications. In particular, along with others, we have shown that the (c-Fos:c-Jun)/AP-1 dimer activity is regulated by conjugation of small ubiquitin-like modifiers. 7, 8 SUMO-1, -2 and -3 are peptidic post-translational modifiers that are covalently and reversibly conjugated to specific lysines of proteins involved in virtually all cellular pathways. 9, 10 Deregulation of the SUMO pathway is implicated in various pathological disorders, in particular cancer. 11 The SUMOylation process involves a specific dimeric E1-activating enzyme (Sae1/Sae2), an E2-conjugating enzyme (Ubc9) and several SUMO E3 factors facilitating the transfer of SUMO to substrates. SUMOylation is highly dynamic because of deSUMOylases of the SENP family. 12 One of the best-documented cellular functions regulated by SUMOylation is transcription. SUMOylation is mostly associated with gene repression in particular through maintenance of chromatin marks associated with repression (H3K9me 3 , H3K27me 3 and H4K20me 3 ) or removal of active transcription-associated marks (H3 and H4 acetylation, H3K4me 3 ). This is achieved via recruitment of various repressor complexes to chromatin. 13 In the case of SUMO, transcriptional activation requires its deconjugation, which leads to the release of co-repressors and allows chromatin-remodeling events that precede pre-initiation complex formation and/or activation of RNA polymerase II. Nevertheless, SUMOylation is also associated with active transcription. First, SUMOylation activates some transcription factors. However, it is unclear whether such a SUMOylation regulates their activity when they are bound to promoters or intervenes at earlier steps. Second, it was recently reported that, relative to repressed genes, SUMOylation is more abundant on both constitutive and inducible genes in Saccharomyces cerevisiae where, for the latter, it delays their deactivation.
14 Finally, high levels of SUMOyled proteins were found on the promoters of highly expressed housekeeping genes in mammalian cells.
Along with others, 8 we 7 have shown that, in transient transfection reporter assays using constitutively expressed proteins, (c-Fos:c-Jun)/AP-1 dimer activity is repressed by SUMOylation. This suggested that SUMOylation of c-Fos and c-Jun might be involved in transcription turn off, as assumed for most SUMOylated transcription factors studied thus far. 16 c-Fos is expressed at low or undetectable levels in cycling cells and its expression, stability and activity are dependent on specific signaling cascades such as the extracellular signal-regulated kinase, p38-and Jun-kinases pathways. We therefore evaluated c-Fos SUMOylation during its physiological induction by TPA. Using an antibody specific for the SUMOylated form of c-Fos, we report that SUMOylated c-Fos is present on a target promoter at the onset of AP-1-induced gene activation and colocalizes with RNA polymerase II within chromatin. Interestingly, inhibiting overall cell SUMOylation or specifically preventing (c-Fos:c-Jun)/AP-1 SUMOylation leads to a stronger transcriptional induction by TPA, indicating that SUMO adjusts expression to optimal levels. Mechanistically, our data suggest that SUMOylation enhances removal of (c-Fos:c-Jun)/AP-1 dimers from target promoters. Finally, we show that binding of c-Fos is concomitant with a global increase in SUMOylation on the promoter of the endogenous AP-1 target gene, GADD153. Targeting SUMOylated c-Fos to this promoter dampens its activation, further confirming the role of SUMOylation in the control of AP-1 target gene induction.
RESULTS AND DISCUSSION
An antibody to SUMOylated c-Fos reveals its binding to an AP-1 target promoter The study of SUMOylation has been hampered by the lack of antibodies recognizing specific SUMO-modified proteins. To address this, we generated a rabbit polyclonal antibody directed to the SUMOylated form of c-Fos, using a T-shaped peptide that reproduces SUMO-2 conjugated to c-Fos-K265, the only SUMOylated lysine in c-Fos 7 (Supplementary Figure 1) . The specificity of the purified antibody for c-Fos SUMOylated on K265 was first validated by immunoblotting on in vitro SUMOylated c-Fos (Figure 1a and Supplementary Figure 1) . To further establish its specificity, we resorted to tetracycline-inducible c-Fos-and nonSUMOylatable c-Fos-K265R mutant-expressing Flip-In T-Rex 293 cells, which were previously stably transfected with a luciferase reporter gene under the control of a minimal promoter harboring four tandemly repeated TREs (4 Â TRE-luc). 17 Wild-type and mutant c-Fos expression was induced with doxycycline and TPA was added to activate the expression of c-Fos dimerization partners, such as c-Jun, as well as kinases ensuring the c-Fos phosphorylations necessary for full transcriptional activity. The antibody recognized K265-SUMOylated c-Fos, but not nonmodified c-Fos, in immunoblotting of cell extracts where both wild-type and non-SUMOylatable c-Fos were induced at similar levels ( Figure 1b) . Although some unspecific bands were also detected on the immunoblots, the c-Fos-SUMO antibody precipitated the 4 Â TRE sequence only from c-Fos-, but not c-Fos-K265R-expressing cells, in chromatin immunoprecipitation assays (ChIP; Figure 1c ), confirming its specificity in this assay. Thus, we generated the first antibody specific for the SUMOylated form of a protein, namely c-Fos, and thereby provided the first direct evidence of the presence of a SUMOylated protein on a gene promoter.
SUMOylated c-Fos is present on an AP-1 target promoter early during transcriptional activation and colocalizes with RNA polymerase II on chromatin Next, we addressed endogenous c-Fos SUMOylation during induction using the Flip-In T-Rex 293 4 Â TRE-luc cells stimulated by TPA. Under this condition, c-Fos, which is present in small amount in non-stimulated cells, starts to accumulate 1 h after TPA induction and immunoblotting analysis with anti-c-Fos-SUMO antibody showed that SUMOylated c-Fos follows the same kinetics of accumulation as non-modified c-Fos (Supplementary Figure 2) . Association of c-Fos and c-Fos-SUMO with the 4 Â TRE promoter was then assessed by ChIP. c-Fos binding (assayed with an antibody that does not discriminate between SUMOylated and non-SUMOylated c-Fos) occurred within 1 h and reached a maximum between 2 and 6 h post-stimulation, depending on the experiment (Figure 2a and Supplementary Figure 4) . SUMOylated c-Fos was also detected on the 4 Â TRE promoter and followed the same kinetics of accumulation as c-Fos (Figure 2b and Supplementary Figure 4) . This kinetics corresponded to the appearance of luciferase mRNA (Figure 2c ), increased levels of H3K4me 3 , a marker of active promoters, and decreased histone H3 levels, consistently with the idea of lower nucleosome density on active promoters (Figure 2d To confirm, at the single-cell level, the association of SUMOylated c-Fos with chromatin, we resorted to the proximity ligation assay, 18 which allows, in particular, visualizing physical proximity between two different proteins, even poorly abundant because of the inclusion of a rolling circle amplification step. The experiments were carried out on TPA-induced cells after removal of proteins not associated with chromatin. As immunofluorescence with anti c-Fos-SUMO antibodies turned out not to be sensitive enough to detect SUMOylated c-Fos on its own, we used proximity ligation assay with c-Fos-SUMO and SUMO-1 or SUMO-2 antibodies in a first step. The visualization of specific dots (none being observed when one of the primary antibodies was omitted) confirmed the presence of SUMOylated c-Fos on chromatin (Supplementary Figure 5) . In a second step, we used proximity ligation assay to detect association between SUMOylated c-Fos and RNA polymerase II within chromatin ( Figure 2f and Supplementary Figure 6 ), further supporting the idea that SUMOylated c-Fos is present on active genes.
Thus taken together, our data indicate that c-Fos SUMOylation occurs on promoters during target gene activation and suggest that binding of SUMOylated c-Fos to its target promoters is not necessarily linked to gene silencing, as suggested for many transcription factors and co-regulators. 13 These results are, however, in line with the recent observation in budding yeast and in mammalian cells that SUMO and Ubc9 can be found on active promoters that are essentially those of constitutively expressed genes. 14, 15 SUMOylation limits TPA-induced transcription As we have previously found that the (c-Fos:c-Jun)/AP-1 dimer is repressed by SUMOylation when constitutively expressed, our results here raised the question of the role of AP-1 SUMOylation during transcriptional induction. To address the role of early c-Fos SUMOylation on transcriptional induction, we repeated the experiments above when Ubc9 levels were reduced by RNA interference (Supplementary Figure 3) . This led to increased luciferase mRNA accumulation ( Figure 3a ) and increased H3K4me 3 levels on the 4 Â TRE promoter (Figure 3b Importantly, tethered dimers, in which c-Jun and c-Fos are fused via a flexible linker, were shown to faithfully recapitulate the biological activity of the normal dimer. 19 We induced the expression of wild-type or non-SUMOylatable c-Jun:c-Fos dimers with doxycycline, but without TPA, to avoid activating expression of endogenous AP-1. Under these conditions, c-Jun:c-Fos3KR was significantly more effective than c-Jun:c-Fos at stimulating 4 Â TRE-luc transcription (Figure 3d ), although both chimeric proteins were expressed at a similar level (Figure 3c ; the quantification of three independent experiments is shown in Supplementary Figure 7) . This indicated that, in the context of a chromatinized, integrated reporter gene, SUMOylation of (c-Fos:c-Jun)/AP-1 dimers acts to limit its transcriptional activity. To begin to address the molecular mechanisms underlying this, we used ChIP to measure the binding of wild-type and mutant c-Jun:c-Fos dimers on the 4 Â TRE promoter after induction. Interestingly, c-Jun:c-Fos3KR accumulated to a higher level than c-Jun:c-Fos on the 4 Â TRE promoter, although both proteins were expressed at same levels (Figure 3e ). c-Fos and SUMOylated c-Fos show similar affinities for the TRE in in vitro bandshift assays, 7 which suggests that SUMOylation of AP-1 in vivo activates a mechanism that reduces its presence on a binding site within chromatin via the intervention of still-to-be-identified partners. 17 and relative quantitative PCR (qPCR) quantification showed that two copies of the transgene were integrated in their genome (data not shown). Cells were seeded (5.10 6 cells per 10 cm diameter plate) and stimulated 72 h later with doxycycline (Dox; 100 ng/ml) and TPA (20 nM) for the indicated times before immunoblotting analysis (b) with anti-HA and -c-Fos-SUMO antibodies. (c) ChiPs were carried out after 2 h of induction with both antibodies. A pre-immune serum (immunoglobulin G (IgG)) was used as a nonspecific control in ChIPs. ChIPs were performed as previously described 31 except that cells were fixed in 1% methanol-free paraformaldehyde at room temperature for 8 min. Nuclear lysates were sonicated using the Bioruptor UCD-200 sonifier (Diagenode, Liege, Belgium; 20 cycles of 30-s on and 30-s off, highest power). The data obtained using the Roche LightCycler 480 real-time qPCR device (Roche, Basel, Switzerland) were normalized to inputs taken from samples before immunoprecipitation and processed in parallel (n ¼ 3, means±s.d., **Po0.01).
AP-1 SUMOylation on TRE limits their activation D Tempé et al
SUMOylation has been implicated in the clearance of the transcription factors Gcn4 and PEA3 from chromatin. 14, 20, 21 For PEA3, this is associated with ubiquitin-mediated proteolysis, which requires the SUMO-dependent ubiquitin-ligase RNF4. 21 In the case of Gcn4, SUMO-mediated clearance from its target promoter also involves its degradation after phosphorylation by the mediator component Srb10. 20 Taken together, the data obtained with AP-1, PEA3 and Gcn4 suggest that SUMOylation-mediated clearance of regulatory proteins from promoters might represent a general mechanism to regulate transcription. 32 In brief, Luciferin (0.5 mM) was added at least 10 h before TPA induction. Luminescence images were obtained using a Nikon PLAN 10 Â /0.25 dry objective (Nikon, Tokyo, Japan) and captured using a Back-Thinned Electron Multiplying CCD Camera (ImagEM, Hamamatsu Photonics, Hamamatsu, Japan). Sequential images were integrated using 4 Â 4 binning over 30 min. Images acquisition and analysis were performed using the MetaMorph Microscopy Automation software (Molecular Devices Corporation, Sunnyvale, CA, USA). Dark area average intensity was subtracted from the luminescence signal of each pixel. Average intensities were collected from every single cell within the field during the indicated times and are represented separately. Luminescence mean was calculated for the whole field and is represented as a thick line (n ¼ 3 with similar outcomes. A representative experiment is shown). (f ) c-Fos-SUMO colocalizes with RNA Polymerase II on chromatin. 4 Â TRE-luc cells, grown on 10-well glass slides coated with polylysine, were stimulated with TPA (20 nM) for 4 h. Cells were then treated with 10 mM Tris pH7.4, 300 mM Sucrose, 100 mM NaCl, 3 mM MgCl 2 , 1 mM EGTA, 0.5% Triton X100, 1 mg/ml leupeptin/ aprotinin/pepstatin, 10 mM NEM for 10 min at 4 1C to remove all soluble proteins and keep only chromatin-associated factors, as previously described. 33 Cells were then fixed in 4% paraformaldehyde for 15 min at room temperature and washed with phosphate-buffered saline (PBS) þ 10 mM glycine and incubated in blocking buffer (PBS þ 0.8% bovine serum albumin) at 37 1C for 30 min. c-Fos-SUMO and anti-RNA polymerase II antibodies (8WG16, Covance, Princeton, NJ, USA) were used alone or in combination. Proximity ligation assay (PLA) was performed using the rabbit PLUS and mouse MINUS (1/15 dilution each) Duolink kits with green fluorochrome (OLINK Bioscience, Uppsala, Sweden) according to the manufacturer's protocol. Nuclei were stained with Hoechst 33342 (Sigma). Images were acquired on Leica SP5-SMD confocal microscope (Leica, Wetzlar, Germany) and stacks of all Z plans are presented. Only the condition with both anti-c-Fos-SUMO and anti-RNA polymerase II is shown here. Images including negative controls are shown in Supplementary Figure 6 . Figures 2a and b) . This precluded detection of SUMOylated c-Fos on endogenous AP-1 target genes, because they contain generally only one or several separated TREs. We therefore tested whether global SUMOylation of promoter-bound proteins could be associated with active transcription using the endogenous AP-1 target gene, GADD153. This gene encodes a transcriptional regulator that enhances expression of specific genes, in particular via direct interactions with AP-1. 22 The sole characterized TRE in its promoter is required for GADD153 induction by various stimuli. 23 TPA-induced transcriptional activation of GADD153 was associated with a strong enrichment in c-Fos binding to the TRE (Figure 4a ) and a significant increase in SUMO-2 starting 1-2 h poststimulation (Figure 4b) . To address the link between these two observations, we fused c-Fos to the SUMO E2 enzyme Ubc9 in order to enhance c-Fos SUMOylation. This Ubc9-fusion-directed SUMOylation approach allows strong increase in target protein SUMOylation 24 and has proven successful to characterize the role of SUMOylation of various proteins such as HP-1 25 or Mek1. 26 The c-Fos-Ubc9 gene was inserted as single copy in the 
24
) was cloned in the PCDNA5-FRT-TO vector (Invitrogen) and inserted as a single copy by recombination in Flip-In T-Rex 293 4 Â TRE-luc cells. (c) Cells were induced for 6 h with TPA (20 nM) with or without doxycycline (Dox; 100 ng/ml) and immunoblottings were carried out with anti-c-Fos or c-Fos-SUMO antibodies. (d) The same cells were treated with TPA (20 nM) with or without Dox (100 ng/ml) for 4 h before ChIP analysis using an anti-Ubc9 (Covance) antibody as described in (b). Data are expressed as percentages of DNA input (n ¼ 3, mean±s.d., **Po0.01). (e) Cells were induced for 6 h with TPA (20 nM) with or without Dox (100 ng/ml) before GADD153 mRNAs levels were assayed by reverse transcriptase (RT)-qPCR. Data were normalized to S26 expression and are expressed as ratios to non-induced cells (n ¼ 4 with similar outcomes. As a result of the variations in the levels of induction between experiments, a single experiment is shown. Data are presented as mean ± s.d. from triplicate qPCRs).
AP-1 SUMOylation on TRE limits their activation D Tempé et al
Ubc9 was recruited to the TRE element of the GADD153 promoter, as determined by ChIP using anti-Ubc9 antibodies (Figure 4d) . Induction of c-Fos-Ubc9 expression significantly diminished TPA induction of GADD153 mRNA (Figure 4e ). These results show that SUMOylation can be rapidly detected on an endogenous TRE-containing promoter, where, again, it limits transcriptional activation. SUMOylation of promoter-bound proteins, in particular transcription factors, is generally believed to occur when gene expression must be turned off. Our work demonstrates that SUMOylation can also be associated with the early steps of transcriptional induction in human cells, at least in the case of AP-1 target genes. On individual promoters, AP-1 SUMOylation would thus act either to limit transcription efficiency or to inactivate momentarily the promoter. In both cases, SUMOylation of (c-Fos:c-Jun)/AP-1 would constitute a 'rheostat' avoiding excessive level of transcription. Such a mechanism would allow fine regulation of transcription in the case of specific co-signaling. In particular, various stresses regulate SUMOylation, 27 including heat shock and oxidative stress, both of which lead to rapid c-Fos deSUMOylation. 7, 28, 29 This could serve to increase transcription of specific AP-1 target genes involved in the cellular response to such stresses. Similarly, Ras-induced deSUMOylation of c-Fos via its increased phosphorylation on threonine 232
7 could serve to hyper-activate genes involved in tumorigenesis. Many transcription factors are recruited to chromatin after specific stimuli. Therefore, their SUMOylation during transcriptional activation could be a general way to tightly control the expression of their target genes. Studies with antibodies directed to their SUMOylated forms, like the anti-SUMOylated c-Fos antibody we describe here, should enable further exploration of the dynamics of gene regulation and the fine tuning that is involved in this multi-layered process.
